Endpoint Health is on a mission to address urgent needs in immune-driven critical and chronic illnesses by delivering therapies that are personalized to each patient’s biology. We built Endpoint Health from the ground up to develop and commercialize therapeutics and therapy-guiding tests, to ensure that every patient receives personalized treatment that will dramatically improve their outcomes. Our vision is a world in which all patients have effective, personalized treatment, because therapies are targeted to the right patient at the right time.
Location: United States, California, Palo Alto
Employees: 11-50
Total raised: $52M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 04.09.2021 | Y Combinat... | ycombinato... |
| - | Humboldt | humboldtfu... |
| - | Wireframe ... | wireframev... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.06.2022 | - | $52M | - | - |
Mentions in press and media 1
| Date | Title | Description | Source |
| 27.08.2021 | AstraZeneca promotes oncology exec to CMO; Pfizer re... | Cristian Massacesi The biggest bright spot for AstraZeneca over the last few years has been it... | endpts.com... |